InsidersTradesSigma
PHARMANUTRA PHARMANUTRA - PHN: IL CDA APPROVA IL PROGETTO DI BILANCIO DI ESERCIZIO E IL BILANCIO CONSOLIDATO AL 31 DICEMBRE 2025: management transactions · Italy · Consob
CONSOB:pharmanutra-pharmanutra-phn-il-cda-approva-il-progetto-di-bilancio-di-esercizio-IT·ConsobMcap 862M€Healthcare
Browse the full insider trade history of PHARMANUTRA PHARMANUTRA - PHN: IL CDA APPROVA IL PROGETTO DI BILANCIO DI ESERCIZIO E IL BILANCIO CONSOLIDATO AL 31 DICEMBRE 2025, a listed equity based in Italy. Shares are quoted on IT IT, under the supervision of Consob. Operating in the Healthcare sector, PHARMANUTRA PHARMANUTRA - PHN: IL CDA APPROVA IL PROGETTO DI BILANCIO DI ESERCIZIO E IL BILANCIO CONSOLIDATO AL 31 DICEMBRE 2025 has logged 1 reports. Market capitalisation: €861.8m. The latest transaction was filed on 17 March 2026 — Other. Among the most active insiders: Unknown. All data is openly available.
1
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
90.00 €
Analyst consensus
3 analystsStrong buy
76.00 €Target 81.33 €(-10%)86.00 €
Income statement
Revenue132.9 M€
Gross profit102.9 M€77% margin
Net income20.0 M€15.2% margin
Valuation
PER (trailing)40.9x
PER (forward)29.4x
P/Book12.1x
Balance sheet & cash
Market cap861.8 M€
Total debt20.5 M€
Free Cash Flow16.4 M€
Debt / Equity26%
Profitability & ownership
ROE30.1%
ROA15.1%
% insiders65.0%
% institutions16.1%
Last declaration on 17 March 2026
Declarations1 total
Executives●Other0Consob
CONSOB:179092·details not loaded
1 of 1 declaration